Regulation of alveolar gas conductance by NO in man, as based on studies with NO donors and inhibitors of NO production

Acta Physiologica

Volumn 196, Issue 2, 2009, Pages 267-277

  Guazzi, M ^a   Arena, R ^b   Vicenzi, M ^a   Guazzi, M D ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Gas diffusion; Nitric oxide; Pulmonary circulation

Indexed keywords

ARGININE; CARBON MONOXIDE; DEXTRO ARGININE; GLUCOSE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE DONOR;

ADULT; ARTICLE; BLOOD VOLUME; CAPILLARY WALL; CONTROLLED STUDY; HEART OUTPUT; HUMAN; LUNG ARTERY PRESSURE; LUNG CAPILLARY; LUNG DIFFUSION CAPACITY; LUNG GAS EXCHANGE; LUNG VASCULAR RESISTANCE; MALE; MEMBRANE CONDUCTANCE; NORMAL HUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; RESPIRATORY FUNCTION;

ADULT; ARGININE; BLOOD PRESSURE; BREATH TESTS; CARBON MONOXIDE; ENZYME INHIBITORS; HUMANS; LUNG VOLUME MEASUREMENTS; MALE; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PULMONARY CIRCULATION; PULMONARY DIFFUSING CAPACITY; PULMONARY GAS EXCHANGE; VASCULAR RESISTANCE; VEHICLES; YOUNG ADULT;

EID: 65449166777     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2008.01939.x     Document Type: Article

References (44)

1. Abbas, A.E., Fortuin, F.D., Shiller, N.B., Appleton, C.P. Moreno, C.A. 2003. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41, 1021 1027. (Pubitemid 36315548)
2. American Thoracic Society; European Respiratory Society. 2005. ATS/ERS recommendations for standardized procedures for online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171, 912 930. (Pubitemid 40562723)
3. Archer, S.L., Tolins, J.P., Raij, L. Weir, E.K. 1989. Hypoxic pulmonary vasoconstriction is enhanced by inhibition of the synthesis of an endothelium derived relaxing factor. Biochem Biophys Res Commun 164, 1198 1205. (Pubitemid 19283971)
4. Azzam, Z.S., Dumasius, V., Saldias, F.J., Adir, Y., Sznajder, J.I. Factor, P. 2002. Na,K-ATPase overexpression improves alveolar fluid clearance in a rat model of elevated left atrial pressure. Circulation 105, 497 501. (Pubitemid 34141708)
5. Charkoudian, N., Joyner, M.J., Barnes, S.A., Johnson, C.P., Eisenach, J.H., Dietz, N.M. Wallin, B.G. 2006. Relation between muscle sympathetic nerve activity and systemic hemodynamics during nitric oxide synthase inhibition in humans. Am J Physiol Heart Circ Physiol 291, H1378 H1383. (Pubitemid 44343684)
6. Cooper, C.J., Landzberg, M.J., Anderson, T.J., Charbonneau, F., Creager, M.A., Ganz, P. Selwyn, A.P. 1996. Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans. Circulation 93, 266 271. (Pubitemid 26031484)
7. Cummings, J.J. 1997. Nitric oxide decreases lung liquid production in fetal lambs. J Appl Physiol 83, 1538 1544. (Pubitemid 27495328)
8. Cummings, J.J. Wang, H. 2001. Nitric oxide decreases lung liquid production via guanosine 3,5 cyclic monophosphate. Am J Physiol 280, L923 L929. (Pubitemid 32436057)
9. Davidge, S.T. 2001. Prostaglandin H synthase and vascular function. Circ Res 89, 650 660. (Pubitemid 34627064)
10. De Pasquale, C.G., Arnolda, L.F., Doyle, I.R., Grant, R.L., Aylward, P.E. Bersten, A.D. 2003. Prolonged alveolo-capillary barrier damage after acute cardiogenic pulmonary edema. Crit Care Med 31, 1060 1067. (Pubitemid 36444414)
11. Driss, A.B., Devaux, C., Henrion, D., Duriez, M., Thuillez, C. Levy, B.I. 2000. Hemodynamic stresses induce endothelial dysfunction and remodeling of pulmonary artery in experimental compensated heart failure. Circulation 101, 2764 2770. (Pubitemid 30390582)
12. Dweik, R.A., Laskowski, D., Abu-Soud, H.M., Kaneko, F.T., Hutte, R. Stuehr, D. 1998. Nitric oxide synthesis in the lung. Regulation by oxygen through a kinetic mechanism. J Clin Invest 101, 660 666. (Pubitemid 28084250)
13. Gamboa, A., Shibao, C., Diedrich, A., Choi, L., Pohar, B., Jordan, J., Paranjape, S., Farley, G. Biaggioni, I. 2007. Contribution of endothelial nitric oxide to blood pressure in humans. Hypertension 49, 170 177. (Pubitemid 46360357)
14. Guazzi, M. 2000. Alveolar-capillary membrane dysfunction in chronic heart failure: pathophysiology and therapeutic implications. Clin Sci 98, 633 641. (Pubitemid 30386425)
15. Guazzi, M. 2003. Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124, 1090 1102. (Pubitemid 37123333)
16. Guazzi, M., Agostoni, P.G., Bussotti, M. Guazzi, M.D. 1999. Impeded alveolar-capillary gas transfer with saline infusion in heart failure. Hypertension 34, 1202 1207. (Pubitemid 30002383)
17. Guazzi, M., Agostoni, P.G. Guazzi, M.D. 2001a. Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril and not by losartan, in chronic heart failure. J Am Coll Cardiol 37, 398 406. (Pubitemid 32147244)
18. Guazzi, M., Agostoni, P.G. Guazzi, M.D. 2001b. Alveolar-capillary gas exchange and exercise performance in heart failure. Am J Cardiol 88, 452 457. (Pubitemid 32823318)
19. Guazzi, M., Pontone, G., Brambilla, R., Agostoni, P. Rèina, G. 2002. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 23, 467 473. (Pubitemid 35204186)
20. Guazzi, M., Tumminello, G., Di Marco, F., Fiorentini, C. Guazzi, M.D. 2004. The effects of phosphodiesterase-5 inhibition with sildenafil on pulmonary hemodynamics and diffusion capacity, exercise ventilatory efficiency, and oxygen uptake kinetics in chronic heart failure. J Am Coll Cardiol 44, 2339 2348. (Pubitemid 39647608)
21. 2-induced endothelial barrier dysfunction: mechanisms of protection. Am J Physiol 280, L116 L126. (Pubitemid 32473243)
22. Hankinson, J.L., Odenerantz, J.R. Fedan, K.B. 1999. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159, 179 187. (Pubitemid 29036522)
23. 1/FVC ratio below the fifth percentile, not <70%. Chest 131, 349 355. (Pubitemid 46280391)
24. Haynes, W.G., Noon, J.P., Walker, B.R. Webb, D.J. 1993. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11, 1375 1380. (Pubitemid 24008485)
25. Hsia, C.C.W., McBrayer, D.G. Ramanathan, M. 1995. Reference values of pulmonary diffusion capacity during exercise by a rebreathing technique. Am J Respir Crit Care Med 152, 648 665.
26. Hughes, L.M.B. 2005. Pulmonary complications of heart disease. In : Murray Nadel's (ed.) Textbook of Respiratory Medicine, pp. 2200 2222. Elsevier Saunders, Philadelphia.
27. Koizumi, T., Gupta, R., Banerjee, M. Newman, J.H. 1994. Changes in pulmonary vascular tone during exercise. Effects of nitric oxide (NO) synthase inhibition, l-arginine infusion, and NO inhalation. J Clin Invest 94, 2275 2282. (Pubitemid 24379598)
28. Lewis, G.D., Lachmann, J., Carnuso, J., Lepore, J.J., Shin, J. Martinovic, M.E. 2007. Sildenafil improves exercise hemodynamics and oxygen uptake in patients with systolic heart failure. Circulation 115, 59 66. (Pubitemid 46058612)
29. Liu, S.F., Crawley, D.E., Barnes, P.J. Evans, T.W. 1991. Endothelium-derived relaxing factors inhibit hypoxic pulmonary vasoconstriction in rats. Am Rev Resp Dis 143, 32 37.
30. Matthay, M.A., Folkesson, H.G. Verkman, A.S. 1996. Salt and water transport across alveolar and distal airway epithelia in the adult lung. Am J Physiol 270, L487 L503. (Pubitemid 26148321)
31. Mayer, B.X., Mensik, C., Krishnaswami, S., Derendorf, H., Eichler, H.G., Schmetterer, L. Wolzt, M. 1999. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide synthase inhibition with l-NMMA in humans. Br J Clin Pharmacol 47, 539 544. (Pubitemid 29199726)
32. Norel, X., Walch, L., Gascard, J.P., de Montpreville, V. Brink, C. 2004. Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone. Br J Pharmacol 142, 788 796. (Pubitemid 38969674)
33. Ogata, M., Ohe, M., Katayose, D. Takishima, T. 1992. Modulatory role of EDRF in hypoxic contraction of isolated porcine pulmonary arteries. Am J Physiol 262, H691 H697.
34. Opie, L.H., Commerford, P.J., Gersh, B.J. Pfeffer, M. 2006. Controversies in ventricular remodelling. Lancet 367, 356 367. (Pubitemid 43151469)
35. Perrella, M.A., Hildebrand, F.L., Marguelis, K.B. Burnett, J.C. 1991. Endothelium-derived relaxing factor in regulation of basal cardiopulmonary and renal function. Am J Physiol 261, 323 328.
36. Predescu, D., Predescu, S., Shimizu, J., Miyawaki-Shimizu, K. Malik, A.B. 2005. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol 289, L371 L381. (Pubitemid 41192711)
37. Puri, S., Dutka, D.P., Baker, L., Leigh, B.Sc., Hughes, J.M.B. Cleland, J.G.F. 1999. Acute saline infusion reduces alveolar-capillary gas conductance and increases airflow obstruction in patients with left ventricular dysfunction. Circulation 99, 1190 1196. (Pubitemid 29120091)
38. Roughton, F.J.W. Forster, F.E. 1957. Relative importance of diffusion and chemical reaction rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillaries. J Appl Physiol 11, 290 302.
39. Sander, M., Chavoshan, B. Victor, R.G. 1999. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. Hypertension 33, 937 942. (Pubitemid 29186388)
40. Shiller, N.B., Shah, P.M., Grawford, M., De Maria, A., Devereux, R. Feigenbaum, H. 1989. For the American Society of Echocardiography Committee on Standards, Subcommittee on quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2, 358 367.
41. Stamler, J.S., Loh, E., Roddy, M.A., Currie, K.E. Creager, M.A. 1994. Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans. Circulation 89, 2035 2040. (Pubitemid 24142778)
42. Tawnsend, M.C. 2007. Conflicting definitions of airways obstruction: drawing the line between normal and abnormal. Chest 131, 335 336. (Pubitemid 46280386)
43. West, J.B. Mathieu-Costello, O. 1995. Vulnerability of pulmonary capillaries in heart disease. Circulation 92, 622 631.
44. Zanen, P., van der Lee, I., van der Mark, T. van der Bosch, J.M.M. 2001. Reference values for alveolar membrane diffusion capacity and pulmonary capillary blood volume. Eur Respir J 18, 764 769. (Pubitemid 33076917)